
    
      Compare the reactogenicity & immunogenicity of GSK Biologicals' combined Vi polysaccharide
      typhoid vaccine & inactivated hepatitis A vaccine, Hepatyrix, to that elicited by GSK
      Biologicals' hepatitis A vaccine, Havrix administered singly or concomitantly with GSK
      Biologicals' Vi polysaccharide vaccine, Typherix, & to that elicited by Aventis Pasteur's
      monovalent Vi polysaccharide vaccine, Typhim Vi, administered intramuscularly to healthy
      subjects aged 18-65 yrs.
    
  